Diasonics will expand advertising and direct-mail promotion programsduring the latter half of this year in support of its VST high-endradiology ultrasound scanner. The firm brought over 100 physiciansto San Francisco last Sunday for an introductory
Diasonics will expand advertising and direct-mail promotion programsduring the latter half of this year in support of its VST high-endradiology ultrasound scanner. The firm brought over 100 physiciansto San Francisco last Sunday for an introductory demonstrationof its VST Masters Series upgrade (SCAN 6/2/93).
Shipments of the upgrade are scheduled to commence in the thirdquarter of this year. A road show to tout the technology is plannedfor September, according to Bruce Moore, Diasonics Ultrasoundpresident and CEO.
Trimmer operations and a focused worldwide ultrasound saleseffort should help Diasonics Ultrasound become profitable in atight ultrasound market, Moore said. The Milpitas, CA, vendorreduced operating costs significantly over the past year, loweringits break-even sales volume.
"We have taken much expense out of the business,"he told SCAN. "This (upgrade) proves that we can offer innovationsyear in and year out with a cost structure that allows us to makemoney at a lower volume than our competitors."
Upon shareholder approval at Diasonics' September annual meeting,ultrasound imaging will separate from both the profitable OECDiasonics speciality x-ray business and an emerging program tocommercialize ultrasound tissue ablation technology, labeled focalsurgery (SCAN 2/24/93).
As a separate company, Diasonics Ultrasound will be betterpositioned to coordinate ultrasound sales and marketing globally,including the efforts of Diasonics' Sonotron and Vingmed Soundsubsidiaries in Europe, Moore said. As president of the currentultrasound division of Diasonics, Moore is responsible only forthe domestic ultrasound business, which involves largely radiologysales of Spectra VST systems.
"The international piece is a separate organization. Vingmedis separate also. We have three ultrasound organizations underone company," he said. "The new company will approachthe ultrasound market on a worldwide basis and look at radiology,cardiac and vascular applications."
The first Spectra scanner was introduced in 1989. Althoughthe Spectra name was dropped with this month's VST upgrade, allof the approximately 1000 Spectra systems installed worldwidecan be upgraded to the latest VST technology. About 300 VST systemshave been installed in the U.S. and another 100 internationally--eitheras new systems or upgrades--since the technology's introductionlast year (SCAN 4/8/92). Diasonics' entire ultrasound installedbase amounts to about 7500 units.
VST Master Series is part of a planned schedule of upgradesand not a reaction to upgrades provided by competitors, Mooresaid. The company must convince customers that it has the wherewithalto maintain a constant flow of upgrades.
"Our strategy for winning in the marketplace is to providesignificant innovations every year and to do this consistently.In that way, we will maintain our credibility and regain our reputationas an innovator, which we had in the early '80s," he said."This is a very competitive market. People want systems thatare at the state of the art not just the day they buy them, butfor five years after that."
Diasonics introduced three new transducers based on its MatchedImpedance technology:
These three probes have been added to the 3.5-MHz abdominaland 10-MHz small-parts Matched Impedance transducers originallyoffered with VST last year. Diasonics developed and manufacturesthese transducers itself. The Matched Impedance technology usescomposite ceramic and epoxy materials that reduce ultrasound reverberationsand clear up near-field haze.
While the recent upgrade improved the performance of VST'sbasic confocal gray-scale imaging technology, one feature, "ultrasoundangiography," expands applications by providing new typesof diagnostic information. Ultrasound angiography provides a nonquantitativeindication of blood flow volume through use of color-flow Doppler.It also allows for the visualization of smaller, low-flow vessels,he said.
"Traditional color has shown both velocity and direction.With ultrasound angiography, we have increased our sensitivitytenfold, allowing (users) to visualize the volume of flow as theywould in angiography," Moore said. "This offers essentiallya brand-new imaging mode that provides ultrasensitive road mappingof vessels."
While parts of the Master Series upgrade, such as a redesignedkeyboard, will be standard revisions in the VST product, bothultrasound angiography and patient-specific imaging will be offeredas system options, he said.
Patient-specific imaging allows the ultrasonographer to changeparameters for optimized scanning of light, average and heavypatients without changing the transducer.
BRIEFLY NOTED:
Siemens and Kodak formalized their previous understanding tocooperate in marketing, sales and service of the Kodak Ektascan2180 laser printer. The two medical imaging vendors will sharetechnical information to facilitate connections between equipmentbuilt by each company.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.